[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81871]], camposKey:0275-5408 2024-01-01 Orthokeratology effect on the corneoscleral profile: Beyond the bull's eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81870]], camposKey:2193-8245 2024-01-01 Senile Cataract Formation Does Not Affect Crystalline Lens Thickness00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80829]], camposKey:1542-2321 2023-08-01 Efficacy of Presbyopia-Correcting Contact Lenses: A Systematic Review319328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=79778]], camposKey:2411-5150 2023-06-01 Amblyopia Treatment through Immersive Virtual Reality: A Preliminary Experience in Anisometropic Children00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74988]], camposKey:1743-4440 2023-02-01 EVO/EVO plus Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism7583, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80360]], camposKey:0165-5701 2023-01-01 Assessment of the iridocorneal angle pigmentation and structures after the implantation of EVO+ Visian Implantable Collamer Lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75057]], camposKey:0950-222X 2023-01-01 Influence of decentration and tilt of Tecnis ZCB00 on visual acuity and higher order aberrations16401645, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80830]], camposKey:0816-4622 2023-01-01 Professional perspective and practice patterns of vision therapy in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75389]], camposKey:0886-3350 2023-01-01 Reliability and agreement of apparent chord mu measurements between static and dynamic evaluations2128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75669]], camposKey:2227-9067 2022-11-01 Clinical Validation of a New Optical Biometer for Myopia Control in a Healthy Pediatric Population00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74989]], camposKey:0165-5701 2022-10-19 Inter-eye and postoperative prediction of vault after implantation of EVO plus Visian phakic implantable collamer lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75140]], camposKey:1542-0124 2022-10-01 Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study6374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75671]], camposKey:2076-3417 2022-05-01 Agreement of Tear Break-up Time and Meniscus Height between Medmont E300 and Visionix VX120+00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75670]], camposKey:2075-4418 2022-05-01 Characterization of Dysfunctional Lens Index and Opacity Grade in a Healthy Population00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64789]], camposKey:1081-597X 2022-01-01 EVO+ Implantable Collamer Lens KS-aquaPORT
Location, Stability, and Impact on Quality of
Vision and Life177183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63808]], camposKey:2193-8245 2022-01-01 Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63784]], camposKey:0002-9394 2021-01-01 Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life117125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53210]], camposKey:0365-6691 2020-01-01 Phakic intraocular lenses: Recent advances and innovations Lentes intraoculares fáquicas: recientes avances e innovaciones178187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53186]], camposKey:0886-3350 2019-01-01 Effect of central hole location in phakic intraocular lenses on visual function under progressive headlight glare sources15911596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53322]], camposKey:2173-9366 2019-01-01 Lentes intraoculares fáquicas de cámara posterior: actuación del óptico-optometrista00][][com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=466]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=465]]][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63695]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62406]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62141]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63695]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62406]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62141]]][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@73b4af0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7064f39f][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d8828, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f965d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f93e6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f914d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f91e8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8325][com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2540]]][com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2540]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=60533]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=60533]]][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5be9bd]][][][][][][][]
